Table: Kyorin Holdings -2019/20 group results

Kyorin Pharmaceutical

12/05/2020 06:30

May 12 (Reuters)- 
          Kyorin Holdings Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales          109.98          113.62         115.50         52.80    
               (-3.2 pct)      (+2.7 pct)     (+5.0 pct)    (+9.3 pct)  
  Operating        7.50            8.97           9.70          2.40    
               (-16.4 pct)     (+1.7 pct)     (+29.3 pct)  (+206.2 pct) 
  Recurring        8.18            9.44          10.20          2.60    
               (-13.4 pct)     (+1.0 pct)     (+24.8 pct)  (+141.6 pct) 
  Net
  Net              6.15            6.87           7.60          1.90    
               (-10.5 pct)     (+4.5 pct)     (+23.6 pct)  (+127.8 pct) 
  EPS          107.35 yen      104.68 yen     132.67 yen     33.17 yen  
  Ann Div       75.00 yen       75.00 yen      75.00 yen                
  -Q2 Div       30.00 yen       30.00 yen      30.00 yen                
  -Q4 Div       45.00 yen       45.00 yen      45.00 yen                
  
  NOTE - Kyorin Holdings Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T